Ortho Clinical Diagnostics
Ortho Clinical Diagnostics Q1 Revenues Rise 24 Percent on Core Revenue Strength
The firm's Q1 core revenues, which exclude contract manufacturing and other licensing revenues, rose 23 percent year over year to $499.3 million.
Ortho Clinical Diagnostics Obtains CE Mark for Quantitative SARS-CoV-2 Antibody Test
The company said that with its IgG test, clinicians and public health leaders have a standard tool to evaluate immune response after infection or vaccination.
Ortho Clinical Diagnostics Gets Additional CE Mark for Coronavirus Antigen Test
The test, which runs on Ortho's Vitros system, was first CE marked in October for use with nasopharyngeal swab specimens and certain viral transport media.
Ortho Clinical Diagnostics to Expand COVID-19 Test Production With $53.7M BARDA, DoD Contract
The firm said the new contract will provide funding to support the production of up to 6.7 million COVID-19 antigen and antibody tests per month for the US market.
Ortho Clinical Diagnostics Q4 Revenues Rise 9 Percent
The firm's Q4 core revenue rose 10 percent year over year to $501 million, driven by high volumes in its Clinical Laboratory and Transfusion Medicine product portfolios.